Daily Management of Patients on Multikinase Inhibitors’ Treatment

In a minority of differentiated thyroid cancer (TC) cases and in a large percentage of poorly differentiated TCs (PDTCs) and anaplastic TCs (ATCs), the prognosis is poor due to the lack of response to conventional treatments. In the last two decades, multikinase inhibitor (MKI) compounds have been d...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Carla, De Leo, Simone, Trevisan, Matteo, Giancola, Noemi, Scaltrito, Anna, Fugazzola, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290676/
https://www.ncbi.nlm.nih.gov/pubmed/35860593
http://dx.doi.org/10.3389/fonc.2022.903532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290676/
https://www.ncbi.nlm.nih.gov/pubmed/35860593
http://dx.doi.org/10.3389/fonc.2022.903532

Ejemplares similares